Clinical Trial Details
| Trial ID: | L3778 |
| Source ID: | NCT02078440 |
| Associated Drug: | Bromocriptine Mesylate |
| Title: | Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Bromocriptine mesylate |
| Outcome Measures: | Primary: Pharmacokinetics, The pharmacokinetic parameters of interest will be Cmax, AUCT and AUC∞ and Tmax. Other parameters including AUCT/∞, Kel, T½el,CL/F, and Vd, will be provided for information purposes., Thirty-six hours | |
| Sponsor/Collaborators: | Sponsor: VeroScience |
| Gender: | ALL |
| Age: | CHILD |
| Phases: | PHASE1 |
| Enrollment: | 18 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2014-01 |
| Completion Date: | 2016-06 |
| Results First Posted: | |
| Last Update Posted: | 2016-08-29 |
| Locations: | Hope Research Institute, Llc, Phoenix, Arizona, 85018, United States|Yale Center for Clinical Investigation, New Haven, Connecticut, 06511, United States|Columbus Clinical Services LLC, Miami, Florida, 33165, United States|The Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Children's Hosptial of Philadelphia, Philadelphia, Pennsylvania, 19104, United States |
| URL: | https://clinicaltrials.gov/show/NCT02078440 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|